Registered outcomes24

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

21 to 24 of 24

List	Outcome	Time frame	Description
Secondary	Best overall response with or without anti-fibrosing treatment	About 6 months
Secondary	Overall health status assessed using the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire	About 6 months
Secondary	Incidence, nature, and severity of adverse events	About 6 months	Graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events, Version 6.0
Secondary	2nd ine part: Incidence, nature, and severity of immune related adverse events	About 6 months	Graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events, Version 6.0

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07420439/registered?page=2